- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
Henry Ji brings 25+ years of experience in the biotechnology and life sciences industry. Dr. Ji is currently serving as Executive Chairman of Semnur Pharma as well as Executive Chairman, Chief Executive Officer and President of Scilex Holding Company . Dr. Ji has been Chairman of Scilex from March 2019 to present and served as … Henry Ji, PhD">Continue reading Henry Ji, PhD
Dorman Followwill was Senior Partner of Transformational Health at Frost & Sullivan, a business consulting firm involved in market research and analysis, growth strategy consulting and corporate training across multiple industries from 2016 to September 2020. Prior to that time, he served in various roles at Frost & Sullivan, including Partner on the Executive Committee … Dorman Followwill">Continue reading Dorman Followwill
Yue Alexander Wu is co-founder and CEO of Cothera Bioscience, Inc., a translation medicine and precision therapeutics company. He was previously President, Chief Executive Officer and Chief Strategy Officer of Crown Bioscience International, a leading global drug discovery and development solutions company, which he co-founded in 2006, until 2017. From 2004 to 2006, Dr. Wu … Alexander Wu, PhD">Continue reading Alexander Wu, PhD
Jay Chun, M.D., Ph.D., has served as the Chief of Neurosurgery and Director of the Atlantic Health Spine Center at Overlook Medical Center at Atlantic Health System since September 2015. Dr. Chun has served as a member of the Company’s Scientific Advisory Board since August 2021 and previously served as a member of Celularity, Inc.’s … Jay Chun, MD, PhD">Continue reading Jay Chun, MD, PhD
PALO ALTO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, and Denali Capital Acquisition Corp., a Cayman Islands exempted company and special purpose acquisition company (Nasdaq: DECA, the … Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion">Continue reading Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion
Henry Ji brings 25+ years of experience in the biotechnology and life sciences industry. Dr. Ji is currently serving as Executive Chairman of Semnur Pharmaceuticals as well as Executive Chairman, Chief Executive Officer and President of Scilex Holding Company . Dr. Ji has been Chairman of Scilex from March 2019 to present and served as … Henry Ji, PhD">Continue reading Henry Ji, PhD
Stephen Ma serves as the Chief Operating Officer, Chief Financial Officer and Senior Vice President since September 2023. Prior to that, Mr. Ma served as the Company’s Chief Accounting Officer and Vice President of Finance. Mr. Ma has more than 20 years of finance and operational expertise across pharmaceuticals and venture backed biotechnology companies. He … Stephen Ma">Continue reading Stephen Ma
Dmitri Lissin currently serves as Chief Medical Officer and Senior Vice President, of Semnur Pharmaceuticals (2015 – present). Prior to Semnur, Dmitri worked for Scilex Holding Company from 2019 to 2025. Prior to that, from 2011-2015, Dmitri was Vice President of Clinical Development at Xenoport, responsible for conduct of multiple clinical research programs in neurology … Dmitri Lissin, M.D.">Continue reading Dmitri Lissin, M.D.
Suketu D. Desai, Ph.D. has 25+ years of experience in the Biologics and Pharmaceutical Industry. Suketu is Chief Technical Officer and Senior Vice President, Chemistry, Manufacturing and Controls, Regulatory CMC, and Quality Assurance at Semnur Pharmaceuticals (2015 – present). Prior to Semnur, Suketu worked for Scilex Holding Company from 2019 to 2025. Prior to that, … Suketu D. Desai, PhD">Continue reading Suketu D. Desai, PhD
Gigi DeGuzman is a seasoned professional with over 25 years of experience in human resources, operations management, facilities management, event planning, executive coordination, and administrative operations. She has played a significant role over the years, working in pharmaceuticals, biotechnology, medical devices, medical aesthetics, high-tech, and solar firms. Gigi has demonstrated leadership and expertise throughout her … Gigi DeGuzman">Continue reading Gigi DeGuzman
